CRPPA and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: These defects were also observed in dystroglycanopathy mouse models with mutations of DG, fukutin, B3GNT1, or ISPD, due to a lack of laminin-binding glycans displayed on α-DG24, 25, 26.